Objective perimetry and progression of multiple sclerosis
暂无分享,去创建一个
T. Maddess | C. Carle | Emilie M. F. Rohan | Jonathan Baird-Gunning | J. V. van Kleef | Christian J. Lueck | C. Lueck | Joshua P. van Kleef
[1] T. Maddess,et al. Comparing Objective Perimetry, Matrix Perimetry, and Regional Retinal Thickness in Mild Diabetic Macular Edema , 2021, Translational vision science & technology.
[2] C. Lebrun-Frénay,et al. Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability. , 2021, Multiple sclerosis and related disorders.
[3] Eman N. Ali,et al. Assessing migraine patients with multifocal pupillographic objective perimetry , 2021, BMC Neurology.
[4] D. Arnold,et al. Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] R. Malik,et al. Abnormal Dynamic Pupillometry Relates to Neurologic Disability and Retinal Axonal Loss in Patients With Multiple Sclerosis , 2021, Translational vision science & technology.
[6] E. McKone,et al. Correlation of Central Versus Peripheral Macular Structure-Function With Acuity in Age-Related Macular Degeneration , 2021, Translational vision science & technology.
[7] D. Piñero,et al. Binocular, Accommodative and Oculomotor Alterations In Multiple Sclerosis: A Review , 2020, Seminars in ophthalmology.
[8] A. James,et al. Localization of Neuronal Gain Control in the Pupillary Response , 2019, Front. Neurol..
[9] M. Comabella,et al. Biomarkers in Multiple Sclerosis. , 2019, Cold Spring Harbor perspectives in medicine.
[10] F. Barkhof,et al. Predicting clinical progression in multiple sclerosis after 6 and 12 years , 2019, European journal of neurology.
[11] C. Lueck,et al. Objective Perimetry in Sporting-Related Mild Traumatic Brain Injury. , 2019, Ophthalmology (Rochester, Minn.).
[12] A. James,et al. Retinotopic effects of visual attention revealed by dichoptic multifocal pupillography , 2018, Scientific Reports.
[13] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[14] Andrew Bell,et al. Comparing multifocal pupillographic objective perimetry (mfPOP) and multifocal visual evoked potentials (mfVEP) in retinal diseases , 2017, Scientific Reports.
[15] A. James,et al. Blue Multifocal Pupillographic Objective Perimetry in Glaucoma. , 2015, Investigative ophthalmology & visual science.
[16] A. James,et al. Luminance and colour variant pupil perimetry in glaucoma , 2014, Clinical & experimental ophthalmology.
[17] A. James,et al. Multifocal Pupillography in Early Age-Related Macular Degeneration , 2014, Optometry and vision science : official publication of the American Academy of Optometry.
[18] A. James,et al. Pupillary response to sparse multifocal stimuli in multiple sclerosis patients , 2014, Multiple sclerosis.
[19] L. Frishman,et al. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis , 2014, Multiple sclerosis.
[20] A. James,et al. The pupillary response to color and luminance variant multifocal stimuli. , 2013, Investigative ophthalmology & visual science.
[21] A. James,et al. Contraction anisocoria: segregation, summation, and saturation in the pupillary pathway. , 2011, Investigative ophthalmology & visual science.
[22] A. Sillito,et al. Always returning: feedback and sensory processing in visual cortex and thalamus , 2006, Trends in Neurosciences.
[23] Rasa Ruseckaite,et al. Sparse multifocal stimuli for the detection of multiple sclerosis , 2005, Annals of neurology.
[24] C. Lueck,et al. Multiple sclerosis seen through new eyes , 2017, Clinical and Experimental Ophthalmology.
[25] S. Graham,et al. Afferent visual pathways in multiple sclerosis: a review , 2017, Clinical & experimental ophthalmology.